- Home
- PROF vs LUCD Comparison
PROF vs LUCD Comparison
Compare PROF & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROF
- LUCD
- Stock Information
- Founded
- PROF N/A
- LUCD 2018
- Country
- PROF Canada
- LUCD United States
- Employees
- PROF N/A
- LUCD N/A
- Industry
- PROF Medical/Dental Instruments
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- PROF Health Care
- LUCD Health Care
- Exchange
- PROF Nasdaq
- LUCD Nasdaq
- Market Cap
- PROF 130.4M
- LUCD 108.0M
- IPO Year
- PROF N/A
- LUCD 2021
- Fundamental
- Price
- PROF $5.89
- LUCD $1.11
- Analyst Decision
- PROF Strong Buy
- LUCD Strong Buy
- Analyst Count
- PROF 1
- LUCD 5
- Target Price
- PROF $11.00
- LUCD $3.70
- AVG Volume (30 Days)
- PROF 63.4K
- LUCD 978.8K
- Earning Date
- PROF 11-13-2025
- LUCD 11-12-2025
- Dividend Yield
- PROF N/A
- LUCD N/A
- EPS Growth
- PROF N/A
- LUCD N/A
- EPS
- PROF N/A
- LUCD N/A
- Revenue
- PROF $11,840,000.00
- LUCD $4,360,000.00
- Revenue This Year
- PROF $60.07
- LUCD $13.90
- Revenue Next Year
- PROF $120.03
- LUCD $154.24
- P/E Ratio
- PROF N/A
- LUCD N/A
- Revenue Growth
- PROF 59.81
- LUCD 14.74
- 52 Week Low
- PROF $3.76
- LUCD $0.75
- 52 Week High
- PROF $9.17
- LUCD $1.80
- Technical
- Relative Strength Index (RSI)
- PROF 54.50
- LUCD 41.94
- Support Level
- PROF $5.65
- LUCD $1.17
- Resistance Level
- PROF $6.28
- LUCD $1.23
- Average True Range (ATR)
- PROF 0.35
- LUCD 0.06
- MACD
- PROF -0.01
- LUCD -0.01
- Stochastic Oscillator
- PROF 62.22
- LUCD 12.20
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.